Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

JnJ News

Sophia Claire 2025 Dec 05, 00:01

Trump's Fed Chair Pick: Power Plays and Monetary Policy in 2025

Noah Lee 2025 Dec 05, 00:00

Diverging Fed Rate Hike Expectations: Will the Fed Defy Forecasts?

Sophia Claire 2025 Dec 05, 00:00

PC Prices Projected to Surge by 2026 Amid AI-Driven Memory Shortage

Noah Lee 2025 Dec 05, 00:00

Gold Outlook 2026: Analyzing Scenarios and Potential Market Impacts

Noah Lee 2025 Dec 05, 00:00

Gold Nears Fair Value Amid Fed Uncertainty: Analyst Outlook

Ghko B 2025 Dec 04, 16:00

Bitcoin price prediction: BTC/USD rebounds, is BTC expected to rise further?

Ghko B 2025 Dec 04, 16:00

Nio stock price prediction: NIO jumps today, will this rally accelerate?

Ghko B 2025 Dec 03, 16:00

Stock opportunities for 2026: TSMC Stock, CRCL Stock, IONQ Stock, NIO

Ghko B 2025 Dec 03, 16:00

Best S&P 500 ETF to buy: Vanguard S&P 500 ETF (VOO), SPY, IVV, iShares ETFs

Ghko B 2025 Dec 03, 16:00

Best CFD Brokers: Award-winning CFD Platforms, markets.com, IG, Pepperstone

Latest news

Show more
Emma Rose 2025 Dec 05, 21:20

Tether Solvency Concerns Addressed: CoinShares Analysis Alleviates Fears

Liam James 2025 Dec 05, 21:10

Bitcoin Miners Squeezed, Ether Derivatives Surge, Kalshi Secures Massive Funding

Liam James 2025 Dec 05, 21:00

Mugafi & Avalanche Partner to Tokenize Entertainment IP, Aiming for $1B in Financing

Sophia Claire 2025 Dec 05, 19:10

Crypto Markets Consolidate, Ether Treasury Trade Unwinds, DeFi Regulation Debated

Noah Lee 2025 Dec 05, 17:40

Polymarket Builds Internal Market-Making Team Amid Regulatory Scrutiny

Noah Lee 2025 Dec 05, 16:30

Poland's Crypto Regulation Stalled: MiCA Alignment Implications

Emma Rose 2025 Dec 05, 15:50

Do Kwon Faces Potential 12-Year Prison Sentence in Terraform Labs Collapse

Liam James 2025 Dec 05, 15:10

Texas Buys Bitcoin: Long-Term Strategy or Short-Term Gamble?

Info

Spread

1.23

Spread (%)

0.6114 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

494700560384

Shares Outstanding

2409295102

Earnings Date (Next)

2001-06-13

Div Yield

2025-12-09

Ex-Dividend Date

2025-11-25

Forward annual dividend rate

5.2

Forward annual dividend yield

0.0253

EPS

10.35

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Dec 04, 16:00

How to trade gold: Trading tips on gold CFDs, Short-term trades in XAU/USD

Ghko B 2025 Dec 03, 16:00

What are the most traded indices: how to trade indices CFD with markets.com?

Ghko B 2025 Dec 03, 16:00

Start investing in 2026: trader's guide, how to find the best CFD broker?

Trustpilot